0078-0874 : Kisqali 200 mg Oral Tablet, Film Coated
| NDC: | 0078-0874 |
| Labeler: | Novartis Pharmaceuticals Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Kisqali |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA209092 |
| Rev. Date: |
Appearance:
| Markings: | RIC;NVR |
| Shapes: |
Round |
| Colors: |
 Purple |
| Size (mm): | 11 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 0078-0874-63: 3 BLISTER PACK IN 1 CARTON (0078‑0874‑63) > 21 TABLET, FILM COATED IN 1 BLISTER PACK (0078‑0874‑21)
Active Ingredients:
- Ribociclib Succinate
Dosage Strength:
- 200 mg
Inactive Ingredients:
- Silicon Dioxide
- Crospovidone
- Hydroxypropyl Cellulose, Unspecified
- Magnesium Stearate
- Microcrystalline Cellulose
- Ferrosoferric Oxide
- Ferric Oxide Red
- Lecithin, Soybean
- Polyvinyl Alcohol, Unspecified
- Talc
- Titanium Dioxide
- Xanthan Gum
Pharmaceutical Classes:
- Cytochrome P450 3A Inhibitors [MoA]
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0078-0860 Kisqali 200 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
- 0078-0867 Kisqali 200 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0078-0867Next: 0078-0876 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.